CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award | +78,333 | 89,583 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +33,686 | 33,686 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +5,280 | 5,280 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +39,633 | 39,633 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +21,401 | 21,401 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2021-10-05 | JOHNSON KENNETH ERLAND See Remarks | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award | +26,366 | 26,366 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award | +180,000 | 206,366 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +30,879 | 30,879 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +65,295 | 65,295 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +3,826 | 3,826 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2021-10-05 | Hecht Beth See Remarks | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 18 of 18 · 354 trades